Bellus Health Stock Price, News & Analysis
Company Description
Bellus Health (NASDAQ: BLU) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector. The company has a market capitalization of $1.9B.
BLU stock has declined 100.0% over the past year.
This page provides a comprehensive overview of BLU stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Bellus Health (BLU) stock. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $1.9B, BLU is classified as a small-cap stock with approximately 126.8M shares outstanding.
Latest News
Bellus Health has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition, earnings, clinical trial, conferences. View all BLU news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
BLU Company Profile & Sector Positioning
Bellus Health (BLU) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.